Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer

Colorectal cancer (CRC) is the third most common cancer worldwide. Even if 5‐fluorouracil (5‐FU) is used as the first‐line chemotherapeutic drug, responsiveness is only 20‐30%. Acquired resistance to 5‐FU contributes to both poor patient prognosis and relapse, emphasizing the need to identify biomar...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cell Mol Med
Prif Awduron: Blondy, Sabrina, Talbot, Hugo, Saada, Sofiane, Christou, Niki, Battu, Serge, Pannequin, Julie, Jauberteau, Marie‐Odile, Lalloué, Fabrice, Verdier, Mireille, Mathonnet, Muriel, Perraud, Aurélie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7810928/
https://ncbi.nlm.nih.gov/pubmed/33325631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15752
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg